🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This week at INHSU #INHSU2022, we have several #CHERISHResearchAffiliate and friends presenting. Take a look and see the full roundup online: cherishresearch.org/2022/09/where-…

At #INHSU2022 where @NMartinUCSD shows us Australia's track to #EndHepC, but a global picture that is less uplifting. When will we catch up in USA ?? Universal DAA and syringe access still a distant dream 😭

Put this on the list of "things we should all be doing starting tomorrow". In US too many administrative delays and $ barriers getting medication access w hospitals' controlled formularies... Great work Ane-Kristine and SELIHEP team!

Great poster from Ben Eckhardt NYU Langone Health demonstrating fantastic #HCV treatment outcomes for young people who inject drugs (ST&RT study) #INHSU2022

So SO proud of this little study - Ben Eckhardt presenting our Rapid HCV treatment results at #INHSU2022 - INHSU kristen marks

New @DrugAlcoholDep, lead author #CHERISHResearchAffiliate Shashi Kapadia (Weill Cornell Medicine Population Health Sciences Weill Cornell Infectious Diseases Division) & colleagues released a study that represents the first cost estimate of implementing a hep C treatment program at a syringe service program in the U.S.: sciencedirect.com/science/articl…

Danielle Ryan, lead author and program manager at Weill Cornell Medicine Population Health Sciences, and colleagues developed a customizable budget impact tool to assist jails/prisons with identifying an optimal MOUD delivery model.  Read along now Journal of Substance Use & Addiction Tx (JSAT): sciencedirect.com/science/articl…

Important study led by Dr. Kapadia sheds light on significant HCV treatment gaps among Medicaid enrollees nationally. Shashi Kapadia jamanetwork.com/journals/jaman…

Interventions are needed to increase low treatment uptake for hepatitis C overall and among key populations and ensure equity in treatment within the Medicaid program. ja.ma/3KriC98 Shashi Kapadia @WCM_PHS @CHERISHResearch

Congratulations to Shashi Kapadia and team on new research highlighting disparities in hepatitis c treatment! Weill Department of Medicine Weill Cornell Medicine Population Health Sciences

Research from Shashi Kapadia and colleagues in JAMA Network Open signals the urgent need for public health and policy efforts to improve treatment initiation and reduce treatment disparities for Medicaid beneficiaries with the hepatitis C virus: bit.ly/45djCG2

The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination ✅ Just Accepted 🔗 bit.ly/3L0PkOU via Shashi Kapadia, Weill Cornell Infectious Diseases Division, @WCMPHS, @CHERISHResearch, CDUHR

The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination 🔗 bit.ly/3L0PkOU via Shashi Kapadia Weill Cornell Infectious Diseases Division @CHERISHResearch CDUHR

Inspiring work by inspiring people Ane-Kristine Håvard Midgard SELIHEP - It's time to stop writing "hcv, defer to outpatient" in your consult notes, #idtwitter

🆕 Overdose prevention centers are a proven intervention in preventing overdose deaths but face continuous legal barriers. This lit review by lead author #CHERISHResearchAffiliate Czarina Behrends, PhD, MPH provides economic evidence showing OPCs to be cost-saving: buff.ly/4cHQ2gj

We reviewed the economic research on overdose prevention centers (OPCs), and all the studies provide overwhelming positive evidence that OPCs not only save lives but saves money. Check out the summary from CHERISH below.

Calling all syndemic teams! Tommy Brothers Megan Rose Curtis Ayesha Appa Ellen Eaton @emmakayphd Nathan Nolan, MD MPH @shilpa_vasishta @veruka2 Carlos del Rio @alicecthornton Wendy Fujita serotavirus @LeahHarveyMD @simkimmel @asherjs